• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Urol. Identification of Kidney Transplant Recipients with Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Eur Urol. 2020 Apr 2. pii: S0302-2838(20)30205-0. doi: 10.1016/j.eururo.2020.03.030. [Epub ahead of print]
Identification of Kidney Transplant Recipients with Coronavirus Disease 2019.


Zhang H[SUP]1[/SUP], Chen Y[SUP]2[/SUP], Yuan Q[SUP]3[/SUP], Xia QX[SUP]4[/SUP], Zeng XP[SUP]4[/SUP], Peng JT[SUP]4[/SUP], Liu J[SUP]4[/SUP], Xiao XY[SUP]4[/SUP], Jiang GS[SUP]4[/SUP], Xiao HY[SUP]4[/SUP], Xie LB[SUP]4[/SUP], Chen J[SUP]4[/SUP], Liu JL[SUP]4[/SUP], Xiao X[SUP]4[/SUP], Su H[SUP]5[/SUP], Zhang C[SUP]5[/SUP], Zhang XP[SUP]4[/SUP], Yang H[SUP]6[/SUP], Li H[SUP]4[/SUP], Wang ZD[SUP]7[/SUP].

Author information




Abstract

Coronavirus disease 2019 (COVID-19) is a novel and lethal infectious disease, posing a threat to global health security. The number of cases has increased rapidly, but no data concerning kidney transplant (KTx) recipients infected with COVID-19 are available. To present the epidemiological, clinical, and therapeutic characteristics of KTx recipients infected with COVID-19, we report on a case series of five patients who were confirmed as having COVID-19 through nucleic acid testing (NAT) from January 1, 2020 to February 28, 2020. The most common symptoms on admission to hospital were fever (five patients, 100%), cough (five patients, 100%), myalgia or fatigue (three patients, 60%), and sputum production (three patients, 60%); serum creatinine or urea nitrogen levels were slightly higher than those before symptom onset. Four patients received a reduced dose of maintenance immunosuppressive therapy during hospitalization. As of March 4, 2020 NAT was negative for COVID-19 in three patients twice in succession, and their computed tomography scans showed improved images. Although greater patient numbers and long-term follow-up data are needed, our series demonstrates that mild COVID-19 infection in KTx recipients can be managed using symptomatic support therapy combined with adjusted maintenance immunosuppressive therapy.
Copyright ? 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.



KEYWORDS:

Clinical feature; Coronavirus disease 2019; Kidney transplant recipient


PMID:32249089DOI:10.1016/j.eururo.2020.03.030
 
Back
Top Bottom